Xylocaine Injection, Solution
Product Images NDC 63323-496

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 63323-496). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lid0o 0000 01 Copy

Chemical structure of the active ingredient in Xylocaine MPF, illustrating the molecular arrangement including a benzene ring with two methyl groups, an amide linkage, and diethylamino groups attached to a central carbon, paired with hydrochloride (HCl).*

FDA Label Image

Lid0o 0000 02 Copy

Chemical structure diagram of the active ingredient in Xylocaine MPF, showing a benzene ring with three hydroxyl groups and a side chain containing an amine group, consistent with the molecular structure of lidocaine.*

FDA Label Image

Lid0o 0000 03 Copy

FDA Label Image

Lid0o 0000 04 Copy

Xylocaine-MPF (lidocaine HCl Injection, USP) 1% (10 mg/mL) in a 10 mL ampule. The label specifies it is not for inhalation and is prescription only. Manufactured for Fresenius Kabi, Lake Zurich, IL, made in Norway. NDC 63323-492-08.*

FDA Label Image

Lid0o 0000 05 Copy

Packaging label for Xylocaine MPF (lidocaine HCl Injection, USP) 1% strength, containing 100 mg per 10 mL (10 mg per mL). The label indicates it is methylparaben free and intended for infiltration and nerve block, including caudal and epidural use. It contains five presterilized 10 mL plastic ampule units. Labeler shown is APP Pharmaceuticals, LLC, with Sterile-Pak branding and the Fresenius Kabi logo.*

FDA Label Image

Lid0o 0000 06 Copy

Label for Xylocaine-MPF (lidocaine HCl Injection, USP) 1.5% solution. This product contains 15 mg/mL lidocaine HCl in a 20 mL ampule, totaling 300 mg per ampule. The label indicates it is Rx only and not for inhalation. Manufactured for Fresenius Kabi, Lake Zurich, IL, made in Norway.*

FDA Label Image

Lid0o 0000 07 Copy

Label for Xylocaine-MPF lidocaine HCl Injection, USP, 15 mg/mL (1.5%) in a Sterile-Pak containing five presterilized 20 mL plastic ampule units. The label states 300 mg per 20 mL total dose. It indicates use for infiltration and nerve block including caudal and epidural, and also notes it is methylparaben free and not for inhalation. Manufactured by Fresenius Kabi.*

FDA Label Image

Lid0o 0000 08 Copy

Label for Xylocaine MPF (lidocaine HCl Injection, USP) 20 mg/mL (2%) in a 10 mL ampule. The label includes a barcode, NDC 63323-496-03, and states it is not for inhalation. Manufactured for Fresenius Kabi, Lake Zurich, IL, made in Norway.*

FDA Label Image

Lid0o 0000 09 Copy

Label for Xylocaine-MPF (lidocaine HCl Injection, USP) 2% solution, providing 20 mg/mL concentration. The label states it is methylparaben-free, intended for infiltration and nerve block including caudal and epidural use, and not for inhalation. It contains five presterilized 10 mL plastic ampule units and is from APP Pharmaceuticals, LLC under the Sterile-Pak brand with the Fresenius Kabi logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.